The therapy, P-BCMA-ALL01, demonstrated a 91% overall response rate for the 23 patients participating in the phase 1 trial.

The high-energy fundraiser began in 2022 to raise money for cancer initiatives at Vanderbilt-Ingram Cancer Center and Monroe Carell Jr. Children's Hospital at Vanderbilt.

The study seeks to understand the mechanisms of colorectal cancer and builds on recent Vanderbilt research.

The project seeks to reduce the time for clinical chart abstraction by 90% while maintaining human-level accuracy.

Launched Sept. 17-19 during the World Cancer Congress in Geneva, Switzerland, “Rewriting Cancer” aims to enhance understanding and inspire audiences by exploring the most innovative, inclusive and impactful solutions for cancer prevention, diagnosis, treatment and care globally.

Since 2007, Hyundai Hope on Wheels, which includes funding from Hyundai Motor America and local dealerships, has awarded more than $2 million in funding to pediatric cancer researchers at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

The mechanistic understanding of how cells respond to heat could explain how chronic inflammation contributes to the development of cancer.